Why Has Immuneel Therapeutics Raised Fresh Capital? Cancer-focused biotechnology startup Immuneel Therapeutics has secured more than ₹100 crore ($10.5 million) in a Series B funding round as it looks to …
Funding Times is a modern business and startup media platform covering entrepreneurship, funding, innovation, technology, and global business trends. We spotlight founders, investors, emerging brands, and industry leaders through impactful stories, interviews, press features, and market insights. Our mission is to give visionary businesses and entrepreneurs a powerful voice in the evolving world of finance and innovation.
© 2026 Funding Times –Powered by OG Media.
All Rights Reserved by JMN PRIVATE LIMITED.
